LA SB118 | 2022 | Regular Session
Status
Completed Legislative Action
Spectrum: Bipartisan Bill
Status: Passed on June 15 2022 - 100% progression
Action: 2022-06-15 - Effective date 1/1/2023.
Text: Latest bill text (Chaptered) [PDF]
Spectrum: Bipartisan Bill
Status: Passed on June 15 2022 - 100% progression
Action: 2022-06-15 - Effective date 1/1/2023.
Text: Latest bill text (Chaptered) [PDF]
Summary
Requires medical necessity for genetic testing of certain cancer mutations is based on nationally recognized clinical practice guidelines. (7/1/22) (EN NO IMPACT See Note)
Title
Requires medical necessity for genetic testing of certain cancer mutations is based on nationally recognized clinical practice guidelines. (7/1/22) (EN NO IMPACT See Note)
Sponsors
Roll Calls
2022-06-02 - Senate - Senate Vote on SB 118 CONCUR (#1165) (Y: 34 N: 0 NV: 0 Abs: 4) [PASS]
2022-06-01 - House - House Vote on SB 118 FINAL PASSAGE (#1343) (Y: 95 N: 0 NV: 0 Abs: 10) [PASS]
2022-04-11 - Senate - Senate Vote on SB 118 CO-AUTHORS (#200) (Y: 14 N: 0 NV: 0 Abs: 24) [PASS]
2022-04-11 - Senate - Senate Vote on SB 118 FINAL PASSAGE (#199) (Y: 35 N: 0 NV: 0 Abs: 3) [PASS]
2022-06-01 - House - House Vote on SB 118 FINAL PASSAGE (#1343) (Y: 95 N: 0 NV: 0 Abs: 10) [PASS]
2022-04-11 - Senate - Senate Vote on SB 118 CO-AUTHORS (#200) (Y: 14 N: 0 NV: 0 Abs: 24) [PASS]
2022-04-11 - Senate - Senate Vote on SB 118 FINAL PASSAGE (#199) (Y: 35 N: 0 NV: 0 Abs: 3) [PASS]
History
Date | Chamber | Action |
---|---|---|
2022-06-15 | Senate | Effective date 1/1/2023. |
2022-06-15 | Senate | Signed by the Governor. Becomes Act No. 412. |
2022-06-06 | Senate | Sent to the Governor by the Secretary of the Senate. |
2022-06-05 | House | Signed by the Speaker of the House. |
2022-06-03 | Senate | Enrolled. Signed by the President of the Senate. |
2022-06-02 | Senate | Amendments proposed by the House read and concurred in by a vote of 34 yeas and 0 nays. |
2022-06-01 | Senate | Received from the House with amendments. |
2022-06-01 | House | Read third time by title, amended, roll called on final passage, yeas 95, nays 0. Finally passed, ordered to the Senate. |
2022-05-31 | House | Scheduled for floor debate on 06/01/2022. |
2022-05-19 | House | Read by title, passed to 3rd reading. |
2022-05-19 | House | Rules suspended. |
2022-05-19 | House | Discharged from the Committee on Appropriations. |
2022-05-04 | House | Read by title, amended, recommitted to the Committee on Appropriations. |
2022-05-03 | House | Reported with amendments (9-0). To be recommitted to the Committee on Appropriations. |
2022-04-12 | House | Read by title, under the rules, referred to the Committee on Insurance. |
2022-04-11 | House | Received in the House from the Senate, read by title, lies over under the rules. |
2022-04-11 | Senate | Read by title, passed by a vote of 35 yeas and 0 nays, and sent to the House. Motion to reconsider tabled. |
2022-04-07 | Senate | Read by title. Committee amendments read and adopted. Ordered engrossed and passed to third reading and final passage. |
2022-04-06 | Senate | Reported with amendments. |
2022-03-14 | Senate | Introduced in the Senate; read by title. Rules suspended. Read second time and referred to the Committee on Insurance. |
2022-03-02 | Senate | Prefiled and under the rules provisionally referred to the Committee on Insurance. |